Azzad Asset Management Inc /Adv Pfizer Inc Transaction History

Azzad Asset Management Inc /Adv

$891 Billion
Q3 2024

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$25.89 - $29.73 $1.18 Million - $1.35 Million	-45,562 Reduced 85.31%	7,848 $218 Million
Q4 2023 Apr 01, 2024	BUY	$26.13 - $33.94 $52,782 - $68,558	2,020 Added 3.93%	53,410 $1.54 Billion
Q3 2023 Apr 01, 2024	BUY	$32.09 - $37.51 $57,697 - $67,442	1,798 Added 3.63%	51,390 $1.7 Billion
Q2 2023 Apr 01, 2024	BUY	$36.12 - $41.79 $61,873 - $71,586	1,713 Added 3.58%	49,592 $1.82 Billion
Q1 2023 Apr 01, 2024	BUY	$39.39 - $51.28 $67,199 - $87,483	1,706 Added 3.69%	47,879 $1.95 Billion
Q4 2022 Apr 01, 2024	SELL	$41.75 - $54.5 $804,105 - $1.05 Million	-19,260 Reduced 29.43%	46,173 $2.37 Billion
Q3 2022 Apr 01, 2024	BUY	$43.76 - $53.42 $53,299 - $65,065	1,218 Added 1.9%	65,433 $2.64 Billion
Q2 2022 Apr 01, 2024	BUY	$46.53 - $55.17 $990,995 - $1.18 Million	21,298 Added 49.63%	64,215 $2.98 Billion
Q1 2022 Apr 01, 2024	BUY	$45.75 - $56.69 $373,365 - $462,647	8,161 Added 23.48%	42,917 $2.22 Billion
Q4 2021 Apr 01, 2024	BUY	$41.32 - $61.25 $44,790 - $66,395	1,084 Added 3.22%	34,756 $2.05 Billion
Q3 2021 Apr 01, 2024	BUY	$39.25 - $50.42 $52,438 - $67,361	1,336 Added 4.13%	33,672 $1.45 Billion
Q2 2021 Apr 01, 2024	BUY	$35.91 - $40.68 $25,603 - $29,004	713 Added 2.25%	32,336 $1.27 Billion
Q1 2021 Apr 01, 2024	BUY	$33.49 - $37.77 $324,015 - $365,424	9,675 Added 44.08%	31,623 $1.15 Billion
Q4 2020 Apr 01, 2024	BUY	$33.47 - $42.56 $30,691 - $39,027	917 Added 4.36%	21,948 $808 Million
Q3 2020 Apr 01, 2024	BUY	$31.75 - $37.25 $38,131 - $44,737	1,201 Added 6.06%	21,031 $772 Million
Q2 2020 Apr 01, 2024	BUY	$30.12 - $36.54 $597,279 - $724,588	19,830 New	19,830 $648 Million
Q1 2020 Apr 01, 2024	SELL	$27.03 - $38.62 $566,900 - $809,977	-20,973 Closed	0 $0
Q4 2019 Apr 01, 2024	BUY	$32.92 - $37.36 $197 - $224	6 Added 0.03%	20,973 $693 Million
Q3 2019 Apr 01, 2024	BUY	$32.49 - $42.13 $681,217 - $883,339	20,967 New	20,967 $689 Million
Q1 2015 Apr 03, 2024	SELL	N/A	-19,694 Closed	0 $0
Q4 2014 Apr 03, 2024	SELL	N/A	-384 Reduced 1.91%	19,694 $613 Million
Q3 2014 Apr 03, 2024	BUY	N/A	6,813 Added 51.36%	20,078 $594 Million
Q2 2014 Apr 03, 2024	BUY	N/A	237 Added 1.82%	13,265 $394 Million
Q1 2014 Apr 03, 2024	BUY	N/A	685 Added 5.55%	13,028 $418 Million
Q4 2013 Apr 03, 2024	SELL	N/A	-315 Reduced 2.49%	12,343 $378 Million
Q2 2013 Apr 03, 2024	BUY	N/A	1,233 Added 10.79%	12,658 $364 Million
Q1 2013 Apr 03, 2024	SELL	N/A	-41,985 Reduced 78.61%	11,425 $330 Million
Q4 2012 Apr 08, 2024	SELL	N/A	-4,824 Reduced 25.32%	14,225 $357 Million
Q3 2012 Apr 08, 2024	BUY	N/A	19,049 New	19,049 $473 Million
Q2 2011 Apr 08, 2024	SELL	N/A	-27,150 Closed	0 $0
Q1 2011 Apr 08, 2024	SELL	N/A	-17,693 Reduced 39.46%	27,150 $551 Million
Q4 2010 Apr 08, 2024	SELL	N/A	-8,567	44,843 $785 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.66 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.32 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.43 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.

Account